Name:	ibio_CeilingOnStockOwnershipPercentage
Namespace Prefix:	ibio_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

Potential amount of contingent payments payable by the company upon achievement of specified milestones related to the Company's licensing agreement with AstralBio.

No definition available.

Name:	ibio_PotentialContingentPaymentsRelatedToLicensingAgreement
Namespace Prefix:	ibio_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479402/808-10-50-1

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Amount of cash outflow for fees classified as other.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482740/230-10-45-25

Name:	us-gaap_PaymentsForFees
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

No definition available.